LBO — NACOGDOCHES MEDICAL CENTER
IRR: 16.4% | MOIC: 2.14x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
16.4%
IRR
2.14x
MOIC
$165.7M
Entry EV
$248.1M
Exit EV
$85.2M
Equity Invested
Sources & Uses
S&UTotal · $165.7M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $64.3M | 38.8% | |
| Sub Debt | $16.1M | 9.7% | |
| Equity | $85.2M | 51.5% | |
| Enterprise Value | $160.8M | 97.1% | |
| Transaction Fees | $4.8M | 2.9% | |
| Total Uses | $165.7M | 100.0% |
Interpretation
INTAt 2.14x MOIC and 16.4% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $23.6M |
| Exit Ev | $248.1M |
| Net Debt At Exit | $65.5M |
| Equity At Exit | $182.5M |
| Equity Invested | $85.2M |
| Total Value Created | $97.3M |
| Value From Growth | $79.2M |
| Value From Multiple | $8.0M |
| Value From Deleveraging | $14.9M |